supported by the Hangzhou Medical Health Science and Technology Project [A20220614];Hangzhou Medical Health Science and Technology Project [A20200788];Hangzhou Medical Health Science and Technology Project [A20220558];Zhejiang General Research Project on Medical Health and Science Technology Plan [2021KY949];Public Welfare Technology Research Program in Zhejiang Province [LGF21H190002];Hangzhou Agricultural and Social Development Research Guide Project [20220919Y060]。
Tuberculosis(TB),caused by the Mycobacterium tuberculosis complex(MTBC),is the 13^(th)leading cause of death and the second leading cause of infectious killer after COVID-19(above HIV and AIDS),according to the World ...
funded by the National Key R&D Program [2022YFC2305200];China CDC-Tuberculosis Control and Prevention Project [228711]。
Drug-resistant(DR) tuberculosis(TB) is a growing threat to public health[1]. Fluoroquinolone(FQ) antibiotics have long been used as anti-tuberculosis drugs, and their widespread application has led to the development ...
the Chinese Center for Disease Control and Prevention project[59911905 and 59911916].
Objective To evaluate multidrug resistant loop-mediated isothermal amplification(MDR-LAMP)assay for the early diagnosis of multidrug-resistant tuberculosis and to compare the mutation patterns associated with the rpoB...
supported by National Science and Technology Major Project of China[2018ZX10731301-002]。
Objectives To evaluate the immunogenicity of Mycobacterium intracellulare proteins and determine the cross-reactive proteins between M.intracellulare and M.tuberculosis.Methods Protein extracts from M.intracellulare w...
National Science and Technology Major Project of China [2018ZX10731301-002]
Objective This study aimed to characterize the diagnostic and vaccine potential of a novel Mycobacterium tuberculosisantigen Rv0674. Methods To evaluate thediagnostic potential and antigenicity of Rv0674, IgG was eval...
supported by the Beijing Medical Award Foundation [YJHYXKYJJ-104]
Objective To assess the activities of biapenem against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis. Methods Biapenem/clavulanate(BP/CL) was evaluated for in vitro activity against Myc...
supported by the National Science and Technology Major Project [2018ZX10103001];the National Natural Science Foundation of China [8161101571]
Today, tuberculosis (TB) remains a global public health threat associated with significantly high rates of morbidity and mortality. The World Health Organization's (WHO) Global Tuberculosis Report 2018[1] has reported...
supported by the project 81401647 of Natural Science Foundation of China;Project 2014SKLID104 of State Key Laboratory for Infectious Diseases Prevention and Control;projects 16411967900 of Science and Technology Commission of Shanghai Municipality
Objective In this study, milk from a cow with mastitis was analyzed to determine the presence of mycobacterial infection. Milk quality and security problems pertaining to the safe consumption of dairy products were al...
supported by a grant from the National Basic Research Program of China 2014CB744403;the National Science and Technology Major Project 2014ZX100030002
Objective Mycobacterium avium (M. avium) and Mycobacterium intracellulare (M. intracellulare) are the major causative agents of nontuberculous mycobacteria (NTM)-related pulmonary infections. However, little is ...
supported by Bill&Melinda Gates Foundation Tuberculosis Prevention and Control Project(2009-04-01)
In order to evaluate the performance of a molecular Hain line probe assay (Hain LPA) for rapid detection of rifampicin and isoniazid resistance of Mycobocterium tuberculosis in China, 1612 smear positive patients we...